Viabahn Covered Stent Graft vs. Supera Stent for Severely Calcified Femoropopliteal Lesions: 3-Year Outcomes of the ARMADILLO Study

Viabahn Covered Stent Graft vs. Supera Stent for Severely Calcified Femoropopliteal Lesions: 3-Year Outcomes of the ARMADILLO Study

The ARMADILLO study demonstrated that among patients with bilaterally calcified femoropopliteal lesions, there was no significant difference in 3-year primary patency between treatment with Viabahn covered stent-grafts and Supera stents, according to a study presented by Dr. Kazunori Horie, Sendai Kosei Hospital, Japan, in the Late Breaking Clinical Trial session at CVIT 2025.

The BEASTARS registry enrolled 3,635 consecutive patients who underwent EVT for femoropopliteal lesi...
Continue reading this article
Select an option below:
Go beyond the guidelines
A portal site of complex catheter intervention techniques
About TCROSS NEWS Global

TCROSS NEWS Global is an online medical journal that provides valuable information on Cardiovascular medicine to medical professionals worldwide.
We bring you the latest findings and trends in all areas of cardiovascular medicine. Please register and subscribe for unlimited access to quality Cardiovascular News!

Introducing the main contents
Conference Reports
Conference Reports
Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!
Complex PCI Cases
Complex PCI Cases
Features case reports on patients with complex lesions encountered in daily clinical practice.
Live Demonstration Courses
Live Demonstration CoursesComing soon
In this section you will find live videos of catheter interventions for complex lesions.
What is TCROSS NEWS GLOBAL?
TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Learn more about TCROSS NEWS Global
This website is automatically translated using Google Translate.

Recommendations

High-Risk Plaques Observed by CT and Future Cardiac Events in Patients with FFR-Negative Chronic Coronary Syndrome: The CAPTURE Trial
High-Risk Plaques Observed by CT and Future Cardiac Events in Patients with FFR-Negative Chronic Coronary Syndrome: The CAPTURE Trial
CVIT 2025
Intravascular Lithotripsy for Coronary Lesions in Real-World Practice: Reports from International Registries and a Japanese Single-Center Experience
Intravascular Lithotripsy for Coronary Lesions in Real-World Practice: Reports from International Registries and a Japanese Single-Center Experience
CVIT 2025
Current Status of PCI for ACS in Japan: Insights From the J-PCI Registry and a CVIT Survey
Current Status of PCI for ACS in Japan: Insights From the J-PCI Registry and a CVIT Survey
CVIT 2025
The impact of a Perfusion Balloon for ACS compared with Direct Stent and Conventional Therapy
The impact of a Perfusion Balloon for ACS compared with Direct Stent and Conventional Therapy
CVIT 2025
PICK UP
Challenging Healthcare Marketing Costs toward Achieving Universal Health Coverage
Special
InsighTCROSS
Outcomes of PCI for CTO in Dialysis Patients: Insights From the Japanese CTO-PCI Expert Registry
CCI
Outcomes of PCI for CTO in Dialysis Patients: Insights From the Japanese CTO-PCI Expert Registry
Association Between Stent-Edge Hinge Motion and Calcified Nodule Formation in Stent-Edge Calcified Coronary Lesions
Circ Intervention
Association Between Stent-Edge Hinge Motion and Calcified Nodule Formation in Stent-Edge Calcified Coronary Lesions
Aspirin-Free Strategy in High Bleeding Risk ACS and Non-ACS Patients Undergoing PCI: A Subgroup Analysis of the STOPDAPT-3 Trial
Circ Intervention
Aspirin-Free Strategy in High Bleeding Risk ACS and Non-ACS Patients Undergoing PCI: A Subgroup Analysis of the STOPDAPT-3 Trial
Digital Twin-Guided Patient Specific Rotor Ablation for Persistent Atrial Fibrillation: The CUVIA Trial
ESC 2025
Digital Twin-Guided Patient Specific Rotor Ablation for Persistent Atrial Fibrillation: The CUVIA Trial